TELA Bio (TELA) Current Assets (2018 - 2026)

TELA Bio has reported Current Assets for 9 years, with the latest figure at $54.5 million in Q2 2026.

• On a quarterly basis, Current Assets fell 10.3% year-over-year to $54.5 million in Q2 2026; TTM through Jun 2026 was $54.5 million, a 10.3% decrease from a year earlier, with the FY2025 full-year figure at $75.6 million, down 3.19% from the prior year.
• Current Assets was $54.5 million for Q2 2026 at TELA Bio, down from $64.3 million in the prior quarter.
• The five-year high for Current Assets was $89.2 million in Q2 2023, with the low at $44.1 million in Q3 2024.
• Average Current Assets over 5 years is $63.7 million, with a median of $62.5 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Assets jumped 95.4% in 2023, then plunged 46.35% in 2024.
• Over 5 years, Current Assets stood at $62.4 million in 2022, then grew by 14.86% to $71.7 million in 2023, then increased by 8.85% to $78.1 million in 2024, then dropped by 3.19% to $75.6 million in 2025, then declined by 27.9% to $54.5 million in 2026.
• The last three Current Assets figures came in at $54.5 million (Q2 2026), $64.3 million (Q1 2026), and $75.6 million (Q4 2025), per Business Quant data.